Status:
COMPLETED
Evaluation of Microinjected Amnion-derived Collagen by Dermapen in the Smoothing of Skin Wrinkles
Lead Sponsor:
Egyptian Atomic Energy Authority
Collaborating Sponsors:
Waleed Nemr,Egyptian Atomic Energy Authority
Conditions:
Facial Wrinkles - Rough Texture - Hyperpigmentation
Eligibility:
FEMALE
36-57 years
Phase:
PHASE2
Brief Summary
The aim of this work was to assess the efficacy of irradiated amniotic collagen matrix in comparison with platelet rich plasma in facial rejuvenation.The present study included 20 patients with facial...
Eligibility Criteria
Inclusion
- Patients who did not receive any treatment for aging within the last 6 months.
- Patients who accepted to participate in this study.
Exclusion
- Patients with bleeding, coagulation disorders, severe anemia, liver disease, renal disease, recurrent facial herpes, keloid formation, pregnant, and lactating females.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 8 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06054646
Start Date
May 1 2019
End Date
December 8 2021
Last Update
October 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Egyptain Atomic Energy Authority
Cairo, Egypt, 29